CX
C21 Investments Inc.
CXXIF · OTC
$0.26 -0.11% (-$0.00)
1M +8.47%
Market Cap $31.4M
P/E Ratio -
Div. Yield -
ROE 16.95%
Bulios Fair Price
$0.15
43.3% downside
Trenutna cena
$0.26
Podcenjeno Poštena vrednost Precenjeno
Po podatkih Bulios Fair Price je delnica CXXIF trenutno precenjena glede na svojo tržno ceno. Kako deluje?
Bulios Fair Price je ocena poštene vrednosti delnice iz Buliosovega modela vrednotenja. Je vhod za vašo lastno analizo, ne naložbeno priporočilo. Kako deluje?
Piotroski F-Score Moderate
6/9Valuation
71 /100
Cheap EV/EBITDA 12.95x
P/FCF 22.24x
P/S 1.00x
Growth
28 /100
Declining Rev. growth 8.50%
Book val. growth 36.21%
FCF growth 2.96%
Profitability
28 /100
Weak Gross margin 35.63%
FCF margin 4.48%
Net margin 13.91%
Quality
7 /100
Poor ROIC 85.44%
Asset turnover 0.59x
ROE 16.95%
Debt
55 /100
Moderate Debt/Equity 0.42x
Net debt/EBITDA 2.47x
Current ratio 1.24x
Stability
31 /100
Unstable Beta 1.88x
Profitable years 0
Rev. volatility 6.02%
Bulios Scoring opisuje kakovost in preteklost podjetja, ne prihodnjega donosa. Visok rezultat ni nakupni signal. Izvedite več
Vprašajte StockBota o CXXIF
Online
Sector
Healthcare
Industry
Drug Manufacturers - Specialty & Generic
CEO
Sonny Newman
Employees
114
Headquarters
Vancouver
Prihajajoči dogodki
10 NOV.
Earnings
Upcoming earnings report